je.st
news
Tag: mannkind
MannKind Launches New Direction For Afrezza
2016-01-22 13:43:46| Biotech - Topix.net
MannKind Corporation's long-term CFO and newly chosen CEO, Matt Pfeffer, recently advanced a new blueprint at the J.P. Morgan Healthcare Conference, held two weeks ago, for the company's direction now that MannKind's partnership with Sanofi will be coming to an end.
Tags: direction
launches
afrezza
mannkind
MannKind: Out With The New And In With The Old Game-Plan For Success
2016-01-19 16:23:22| Biotech - Topix.net
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions.
MannKind Co. (MNKD) Upgraded to "Buy" at Zacks Investment Research
2016-01-16 23:09:46| Biotech - Topix.net
The brokerage presently has a $1.00 target price on the biopharmaceutical company's stock. Zacks Investment Research 's price objective indicates a potential upside of 7.71% from the company's current price.
Tags: buy
research
investment
upgraded
A (Potentially) Final Look At MannKind
2016-01-12 21:06:29| Biotech - Topix.net
As everybody reading this article undoubtedly knows by now, Sanofi gave notice last Monday that it was terminating its licensing agreement with MannKind , relinquishing all rights to market Afrezza. Although the speculation about this possibility started circulating very soon after the inhaled insulin was launched, fanned by the small biotech's various vocal detractors, many true believers in the drug, certainly including myself, were stunned by the news, with the stock losing almost half of its already depressed value.
Tags: final
potentially
mannkind
The MannKind Story Has Ended
2016-01-06 17:17:12| Biotech - Topix.net
I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions.